News

Once nearly eradicated, the “old man’s disease” is back and suffocating younger miners. Federal cuts risk putting a solution ...
Referred to as ‘popcorn lung,’ the obstructive lung condition has been challenging clinicians for decades. But more recent ...
Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as ...
Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...
New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...
More and more thoracic CT scans are being performed worldwide in order to detect lung diseases such as bronchial ... Moltz explains, "Our results show that 11% more tumors are automatically ...
The lung cancer surgery market represents a critical segment within the broader oncology and surgical treatment industry. Lung cancer remains one of the most prevalent and deadly cancers worldwide, ...
Global Non Small-Cell Lung Cancer Market, by Type The non-small cell lung cancer market grow at a CAGR of around 9.3% from 2021-2031.
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Three Phase 1 studies support once-daily inhaled administration of mosliciguat with no evidence of serious systemic side ...
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...
JACKSONVILLE, Fla. — A groundbreaking technology designed to attack lung tumors and shorten recovery times for patients is now available at St. Vincent’s Riverside. The Galvanize Aliya System ...